Description: This panel will discuss the current status of NAIC activities with respect to risk-based capital RBC. The potential impact on financial reporting with respect to health products, specifically, indemnity, HMO, disability, and nontraditional products will also be discussed. From the Record of the Society of Actuaries, Vol.21, No. 4a.

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: This presentation is a panel discussion, session number 43PD, from the 2002 Valuation Actuary Symposium, held September 19-20 in Lake Buena Vista, FL. The panelists provide an overview of the current risk-based-capital [RBC] requirements for life insurers, as well as recent and potential changes to RBC. They discuss reinsurance, including off shore solutions. Recent changes they discuss include Phase I C-3, interest-rate risk for annuities and single premium life, common stock changes, and deferred-tax recognition. The panelists also discuss the proposed stochastic modeling standard C-3 Phase II for variable annuities. Discussion from participants is included.

Description: The International Association of Insurance Supervisors (IAIS) continues its development of the Insurance Capital Standard (ICS) with the introduction of ICS 1.0 in summer 2017 and plans for ICS 2.0 in 2019. This session will provide updates on the development of the standards and summarize insights from Field Testing and ICS Consultations. This session will deliver an overview of the framework and provide industry and regulatory perspectives on potential implications and next steps.

Description: This session is about the methods of projecting long-run stock returns using inflation rates from bond yield curves with incremental returns for risk taking based on historical data and the relationship between concurrent, expected and unexpected inflation rates and the rates of return on common stocks and U.S. government bonds and notes. From Record of Society of Actuaries Vol. 5, No. 4.